0.92
price down icon8.00%   -0.08
 
loading
前日終値:
$1.00
開ける:
$1.01
24時間の取引高:
138.72K
Relative Volume:
0.56
時価総額:
$63.35M
収益:
$9.53M
当期純損益:
$-44.61M
株価収益率:
-1.011
EPS:
-0.91
ネットキャッシュフロー:
$-38.32M
1週間 パフォーマンス:
-6.56%
1か月 パフォーマンス:
-25.81%
6か月 パフォーマンス:
+35.41%
1年 パフォーマンス:
-51.32%
1日の値動き範囲:
Value
$0.912
$1.05
1週間の範囲:
Value
$0.912
$1.05
52週間の値動き範囲:
Value
$0.45
$2.26

Cue Biopharma Inc Stock (CUE) Company Profile

Name
名前
Cue Biopharma Inc
Name
セクター
Healthcare (1166)
Name
電話
617-949-2680
Name
住所
40 GUEST STREET, BOSTON, MA
Name
職員
0
Name
Twitter
@cuebiopharma
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
CUE's Discussions on Twitter

CUE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CUE
Cue Biopharma Inc
0.92 63.35M 9.53M -44.61M -38.32M -0.91
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-03-13 開始されました Jefferies Buy
2023-06-26 再開されました Oppenheimer Outperform
2022-11-21 開始されました Piper Sandler Overweight
2022-01-13 開始されました H.C. Wainwright Buy
2022-01-03 開始されました Craig Hallum Buy
2020-11-24 開始されました Berenberg Buy
2020-04-09 開始されました Stifel Buy
2020-01-28 開始されました BTIG Research Buy
2020-01-22 開始されました JMP Securities Mkt Outperform
すべてを表示

Cue Biopharma Inc (CUE) 最新ニュース

pulisher
Mar 24, 2025

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights - The Manila Times

Mar 24, 2025
pulisher
Mar 22, 2025

Bleichroeder LP Increases Stake in Cue Biopharma Inc - GuruFocus.com

Mar 22, 2025
pulisher
Mar 21, 2025

[Top 3] Best Biotech Penny Stocks to Buy in 2025Finbold - Finbold - Finance in Bold

Mar 21, 2025
pulisher
Mar 19, 2025

Cue Biopharma (CUE) Projected to Post Quarterly Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 17, 2025

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength? - Nasdaq

Mar 17, 2025
pulisher
Mar 13, 2025

Cue Biopharma appoints Pasha Sarraf to board By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 12, 2025

Cue Biopharma Appoints Pasha Sarraf to Board - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Cue Biopharma appoints Pasha Sarraf to board - Investing.com

Mar 12, 2025
pulisher
Mar 01, 2025

Cue Biopharma (NASDAQ:CUE) Trading Down 3.8%What's Next? - MarketBeat

Mar 01, 2025
pulisher
Feb 24, 2025

Larger animals really are more prone to cancer, debunking ‘Peto’s paradox’ - Study Finds

Feb 24, 2025
pulisher
Feb 21, 2025

Layoff Tracker: Spotlight Goes Dark After Disappointing Preclinical Data for CRISPR Platform - BioSpace

Feb 21, 2025
pulisher
Feb 20, 2025

HPV+ Recurrent/Metastatic Head and Neck Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Feb 20, 2025
pulisher
Feb 17, 2025

Public Ventures LLC Completes First Public Company Financing as a Broker-Dealer for Cue Biopharma, Inc. (Nasdaq:CUE) - ACCESS Newswire

Feb 17, 2025
pulisher
Feb 12, 2025

Pancreatic Adenocarcinoma Market Growth Projections - openPR

Feb 12, 2025
pulisher
Feb 05, 2025

Cue Biopharma, Inc. (NASDAQ:CUE) Short Interest Update - MarketBeat

Feb 05, 2025
pulisher
Jan 31, 2025

Artiva Biotherapeutics expands board with industry veteran - MSN

Jan 31, 2025
pulisher
Jan 30, 2025

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D. - The Manila Times

Jan 30, 2025
pulisher
Jan 29, 2025

Artiva Biotherapeutics appoints new director and committee members - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

Artiva Biotherapeutics appoints new director and committee members By Investing.com - Investing.com Nigeria

Jan 29, 2025
pulisher
Jan 29, 2025

Artiva expands Board with appointment of Dan Baker, M.D - TipRanks

Jan 29, 2025
pulisher
Jan 29, 2025

Former J&J Drug Development Chief Who Created Multi-Billion Dollar Therapies Joins Rising Biotech Board - StockTitan

Jan 29, 2025
pulisher
Jan 13, 2025

Geode Capital Management LLC Increases Stock Position in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

Jan 13, 2025
pulisher
Jan 13, 2025

Geode Capital Management LLC Purchases 212,394 Shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) - Defense World

Jan 13, 2025
pulisher
Jan 06, 2025

HPV16+ Cancer Clinical and Non-Clinical Studies, Key - openPR

Jan 06, 2025
pulisher
Jan 02, 2025

Cue Biopharma, Inc. (NASDAQ:CUE) Short Interest Up 8.0% in December - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

Cue Biopharma (NASDAQ:CUE) versus FibroGen (NASDAQ:FGEN) Head-To-Head Comparison - Defense World

Jan 02, 2025
pulisher
Dec 27, 2024

The definitive Boston biotech layoff tracker for 2024 - The Business Journals

Dec 27, 2024
pulisher
Dec 25, 2024

Certain Common Stock of Cue Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com

Dec 25, 2024
pulisher
Dec 19, 2024

Cue Biopharma CEO Daniel Passeri buys $30,900 in stock By Investing.com - Investing.com Australia

Dec 19, 2024
pulisher
Dec 18, 2024

Cue Biopharma CEO Daniel Passeri buys $30,900 in stock - Investing.com India

Dec 18, 2024
pulisher
Dec 18, 2024

Insider Buying: Daniel Passeri Acquires 30,000 Shares of Cue Bio - GuruFocus.com

Dec 18, 2024
pulisher
Dec 18, 2024

Cue Biopharma, Inc. (NASDAQ:CUE) CEO Purchases $30,900.00 in Stock - MarketBeat

Dec 18, 2024
pulisher
Dec 16, 2024

Short Interest in Cue Biopharma, Inc. (NASDAQ:CUE) Decreases By 6.5% - MarketBeat

Dec 16, 2024
pulisher
Dec 13, 2024

Cue Biopharma's SWOT analysis: stock pivot to autoimmune focus sparks debate - Investing.com Australia

Dec 13, 2024
pulisher
Nov 29, 2024

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 29, 2024
pulisher
Nov 29, 2024

Cue Biopharma Grants 200,000 Share Option Award to New Development Chief - StockTitan

Nov 29, 2024
pulisher
Nov 29, 2024

Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail

Nov 29, 2024
pulisher
Nov 29, 2024

Strong week for Cue Biopharma (NASDAQ:CUE) shareholders doesn't alleviate pain of five-year loss - Simply Wall St

Nov 29, 2024
pulisher
Nov 25, 2024

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times

Nov 25, 2024
pulisher
Nov 25, 2024

Cue Biopharma CEO to Present Clinical Updates at Piper Sandler Healthcare Conference | CUE Stock News - StockTitan

Nov 25, 2024
pulisher
Nov 25, 2024

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 25, 2024
pulisher
Nov 25, 2024

Cue Biopharma, Inc. (NASDAQ:CUE) Shares Purchased by GSA Capital Partners LLP - Defense World

Nov 25, 2024

Cue Biopharma Inc (CUE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):